MedX Receives MDSAP Certification, The Highest Regulatory Standard In The Medical Device Manufacturing Industry

MISSISSAUGA, Ontario — MedX Health Corp. (“MedX”) (TSX-V: MDX) a leading medical device and software company focused on skin assessment in identifying suspicious moles and lesions by utilizing its SIAscopy optical scanning technology coupled with its SIAscopy on DermSecure™ telemedicine platform, is pleased to announce that it has achieved a recommendation for continued certification on successful completion of an audit under the Medical Device Single Audit Program (“MDSAP”).

MDSAP is a stringent audit process undertaken on medical device manufacturers’ quality management systems that is recognized by regulatory bodies for compliance of the regulatory requirements under ISO-13485:2016 and in addition, those in Canada, the United States and Australia.

“Achieving the MDSAP certification confirms our ongoing commitment to maintaining the highest quality assurance standards within the Medical Device Industry and provides compliance in all of the jurisdictions we are operating in, including Brazil. The entire MedX team is to be commended for the effort put in through this process,” commented Scott Spearn, President & CEO of MedX.-Financial Post